Trond Williksen took up the reins as the new CEO of global aquaculture genetics, health and specialist nutrition business Benchmark last month, tasked with unleashing the potential of the company and returning it to profitability.
Over the past year, Benchmark’s strategy has been focused on divesting businesses which no longer align with its core business, to improve liquidity and get the company in a position where it performs as it should.
“My job is to unleash the potential and get the company to a position where it performs properly,” Williksen told IntraFish.
